Go Freelance Jobs

Eric Lefkofsky: Tempus Labs and Cancer Research

Eric Lefkofsky is a highly influential entrepreneur in Chicago. He has co-founded and founded many startup businesses in and around the city. One of the companies that he co-founded and launched is known as Tempus Labs. The lab has only been open for three years now, and is already known as a top ten health technology startup. Tempus Labs is a highly successful cancer research and biotechnology business. Some of the technologies they have discovered include gene editing, gene therapy, skin cancer diagnosis, sequencing technology for pathogens, glucose monitors, cancer immunotherapy using CAR-T, eye disease artificial intelligence, KardiaBand, and blood pressure watches. Tempus Labs is also in collaboration with almost all Cancer Institutes in the country.

Gene editing and gene therapy were thought to be useless. But, voretigene neparvovec-rzyl was accepted in 2017 for the treatment of blindness from a rare kind of inherited vision loss. Soon, the outcome will be noted whether the therapy was successful or not. Stanford University scientists successfully developed an algorithm to identify benign and malignant lesions. This algorithm should be a sufficient tool for the immense understanding of skin cancer technology.

KardiaBand was designed by AliveCor. It alerts the patient if they have heart rate outliers through an algorithm method. The FreeStyle Libre Flash glucose monitor is used for directly dosing insulin. The Dexcom sensor will monitor an arm or abdomen and send the information to the patient’s smartphone or watch. Also on the list, is a blood pressure smartwatch. It will read the pressure through the radial artery and is now FDA approved.

Next, pathogen sequencing technology uses tools to understand the pathogens genomes for public heath responses as needed. Following this, CAR-T immunotherapy is changing hematologic malignancy treatments. The two drugs approved are Axicabtagene ciloleucel and tisagenlecleucel-T. Last on the list is artificial eye disease technology, it is more easily used for detecting eye diseases.

Eric Lefkofsky graduated with a Juris Doctor from the University of Michigan Law School. He is the author of Accelerated Disruption, and an adjunct professor at the University of Chicago. To learn more go to www.lefkofsky.com.

Learn More: chicago.blueskyinnovation.com/vault/network/lefkofsky-eric/

Leave a Reply